Felix Grant explores the ways in which statistical data analysis is vital to psychology
The use of modelling and simulation tools is a growing trend in automotive design. Beth Sharp finds out why
Multi-parameter optimisation (MPO) in drug discovery is an area thats had incredible uptake recently, says Matt Segall, Optibriums CEO. He explains why
Oil companies are turning to acclerators, such as GPUs and FPGAs, to process data and speed up simulations. Tom Wilkie reports
Compute power means CPUs, CPUs mean heat and heat generally means noise. To quiet things down, developers of deskside HPC systems increasingly turn to liquid cooling, as Paul Schreier discovers
The petrochemical industry is big, efficient and never sleeps. Siân Harris finds out what role informatics plays in keeping this industry running
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
